SCHEMBL19544985

SCHEMBL19544985

O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1cnc(Cl)c(-c2ccc(F)nc2)c1

nearest known ligand 0.77

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 20/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15391435 0.87 ABL1 (1.00) ABL1
SCHEMBL15391148 0.87 ABL1 (1.00) ABL1
SCHEMBL19544737 0.85 ABL1 (0.87) ABL1
SCHEMBL19544726 0.82 ABL1 (0.71) ABL1
SCHEMBL19544789 0.82 ABL1 (0.68) ABL1
SCHEMBL23664164 0.81 ABL1 (0.67) ABL1
SCHEMBL15388664 0.81 ABL1 (0.71) ABL1
SCHEMBL19544742 0.81 ABL1 (0.57) ABL1
SCHEMBL20419225 0.81 ABL1 (0.69) ABL1
SCHEMBL29421212 0.81 ABL1 (0.69) ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017186148-A1 NOVEL HETEROCYCLIC COMPOUNDS AS TYROSINE KINASE BCR-ABL INHIBITORS ASTAR BIOTECH LLC (US) 2017-11-02 — — WO disclosed
Send feedback